Tapewire

Nasdaq · USD

SENS

Senseonics Holdings, Inc.

Export transactions ↓
Tapewire entity
5469
SEC CIK
0001616543
Parsed reports
441

Last 12 months

Inside the activity.

8 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202540
Dec 202500
Jan 202600
Feb 202600
Mar 202620
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202610
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 16, 2022 Filed May 19, 2022 00:08 UTC
Kaufman FrancineDirector · Chief Medical Officer
Tax withholdingCommon Stock 54,538 $1.13 $61,627.94
Disclosure

SEC source: 0001209191-22-030282 · doc4.xml · nonDerivative · entry 1

Kaufman Francine · CIK 0001769791 · Director · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,167,637

F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 23:39 UTC GrantCommon Stock 3,745 $1.94 $7,265.30
Disclosure

SEC source: 0001209191-22-023334 · doc4.xml · nonDerivative · entry 1

Larkin Sharon · CIK 0001898172 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,860

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $7,265.30 divided by $1.94, the closing price of Issuer's common stock on the NYSE American on April 1, 2022.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 23:34 UTC GrantCommon Stock 12,886 $1.94 $24,998.84
Disclosure

SEC source: 0001209191-22-023326 · doc4.xml · nonDerivative · entry 1

DeFalco Stephen P · CIK 0001666964 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,206,217

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $24,998.84 divided by $1.94, the closing price of Issuer's common stock on the NYSE American on April 1, 2022.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 23:36 UTC GrantCommon Stock 7,280 $1.94 $14,123.20
Disclosure

SEC source: 0001209191-22-023329 · doc4.xml · nonDerivative · entry 1

Fiorentino Edward · CIK 0001666972 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 435,019

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $14,123.20 divided by $1.94, the closing price of Issuer's common stock on the NYSE American on April 1, 2022.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 23:37 UTC GrantCommon Stock 4,832 $1.94 $9,374.08
Disclosure

SEC source: 0001209191-22-023331 · doc4.xml · nonDerivative · entry 1

Prince Douglas S · CIK 0001666995 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,914

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,374.08 divided by $1.94, the closing price of Issuer's common stock on the NYSE American on April 1, 2022.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 23:36 UTC GrantCommon Stock 4,977 $1.94 $9,655.38
Disclosure

SEC source: 0001209191-22-023330 · doc4.xml · nonDerivative · entry 1

Steven Edelman · CIK 0001683354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 394,571

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,655.38 divided by $1.94, the closing price of Issuer's common stock on the NYSE American on April 1, 2022.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 23:26 UTC Exercise / conversionStock Option (right to buy) · Derivative 83,900 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0001209191-22-018985 · doc4.xml · derivative · entry 3

Fiorentino Edward · CIK 0001666972 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 83,900 shares

Expires 2022-03-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the exercise of a stock option held by the Reporting Person that was scheduled to expire, if not exercised, on March 14, 2022.

F4 · derivative.exercise_date: Immediately exercisable.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 23:26 UTC SaleCommon Stock 63,553 $1.65 $104,862.45
Disclosure

SEC source: 0001209191-22-018985 · doc4.xml · nonDerivative · entry 2

Fiorentino Edward · CIK 0001666972 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 427,739

F2 · kind: Represents the required number of shares sold to satisfy the exercise price of the expiring option and the Reporting Person's tax obligations resulting from the exercise. Beyond this required number of shares, no additional shares were sold by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.67 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 23:26 UTC Exercise / conversionCommon Stock 83,900 $0.54 $45,306.00
Disclosure

SEC source: 0001209191-22-018985 · doc4.xml · nonDerivative · entry 1

Fiorentino Edward · CIK 0001666972 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 491,292

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the exercise of a stock option held by the Reporting Person that was scheduled to expire, if not exercised, on March 14, 2022.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 00:44 UTC
Goodnow Timothy TDirector · President and CEO
SaleCommon Stock 464,390 $2.46 $1,142,399.40
Disclosure

SEC source: 0001209191-22-009554 · doc4.xml · nonDerivative · entry 2

Goodnow Timothy T · CIK 0001667588 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,737,786

F2 · kind: Represents shares sold to cover tax obligations upon the vesting of RSUs.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 11, 2022 Filed Feb 14, 2022 19:48 UTC
Panlilio MirasolVP Global Sales and Marketing
SaleCommon Stock 105,760 $2.46 $260,169.60
Disclosure

SEC source: 0001209191-22-009558 · doc4.xml · nonDerivative · entry 2

Panlilio Mirasol · CIK 0001667551 · VP Global Sales and Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,083,788

F2 · kind: Represents shares sold to cover tax obligations upon the vesting of RSUs.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 00:46 UTC
JAIN MukulChief Operating Officer
SaleCommon Stock 150,197 $2.46 $369,484.62
Disclosure

SEC source: 0001209191-22-009556 · doc4.xml · nonDerivative · entry 2

JAIN Mukul · CIK 0001667593 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,849,410

F2 · kind: Represents shares sold to cover tax obligations upon the vesting of RSUs.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 00:45 UTC
Horton Kenneth LGC & Corp. Development Advisor
SaleCommon Stock 143,126 $2.46 $352,089.96
Disclosure

SEC source: 0001209191-22-009555 · doc4.xml · nonDerivative · entry 2

Horton Kenneth L · CIK 0001552047 · GC & Corp. Development Advisor

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,217,425

F2 · kind: Represents shares sold to cover tax obligations upon the vesting of RSUs.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 00:49 UTC
Tressler Nick B.Chief Financial Officer
SaleCommon Stock 72,873 $2.46 $179,267.58
Disclosure

SEC source: 0001209191-22-009559 · doc4.xml · nonDerivative · entry 2

Tressler Nick B. · CIK 0001794362 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,410

F2 · kind: Represents shares sold to cover tax obligations upon the vesting of RSUs.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 00:47 UTC
Kaufman FrancineDirector · Chief Medical Officer
SaleCommon Stock 163,870 $2.46 $403,120.20
Disclosure

SEC source: 0001209191-22-009557 · doc4.xml · nonDerivative · entry 2

Kaufman Francine · CIK 0001769791 · Director · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,222,175

F2 · kind: Represents shares sold to cover tax obligations upon the vesting of RSUs.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 00:44 UTC
Goodnow Timothy TDirector · President and CEO
GrantCommon Stock 673,268 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-009554 · doc4.xml · nonDerivative · entry 1

Goodnow Timothy T · CIK 0001667588 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,202,176

F1 · shares: Represents a performance-based restricted stock unit ("RSU") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 19:48 UTC
Panlilio MirasolVP Global Sales and Marketing
GrantCommon Stock 210,020 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-009558 · doc4.xml · nonDerivative · entry 1

Panlilio Mirasol · CIK 0001667551 · VP Global Sales and Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,189,548

F1 · shares: Represents a performance-based restricted stock unit ("RSU") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 00:46 UTC
JAIN MukulChief Operating Officer
GrantCommon Stock 260,483 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-009556 · doc4.xml · nonDerivative · entry 1

JAIN Mukul · CIK 0001667593 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,999,607

F1 · shares: Represents a performance-based restricted stock unit ("RSU") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 00:45 UTC
Horton Kenneth LGC & Corp. Development Advisor
GrantCommon Stock 255,287 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-009555 · doc4.xml · nonDerivative · entry 1

Horton Kenneth L · CIK 0001552047 · GC & Corp. Development Advisor

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,360,551

F1 · shares: Represents a performance-based restricted stock unit ("RSU") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 00:49 UTC
Tressler Nick B.Chief Financial Officer
GrantCommon Stock 165,854 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-009559 · doc4.xml · nonDerivative · entry 1

Tressler Nick B. · CIK 0001794362 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380,283

F1 · shares: Represents a performance-based restricted stock unit ("RSU") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 00:47 UTC
Kaufman FrancineDirector · Chief Medical Officer
GrantCommon Stock 310,884 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-009557 · doc4.xml · nonDerivative · entry 1

Kaufman Francine · CIK 0001769791 · Director · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,386,045

F1 · shares: Represents a performance-based restricted stock unit ("RSU") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 23:16 UTC GrantCommon Stock 5,136 $2.75 $14,124.00
Disclosure

SEC source: 0001209191-22-001944 · doc4.xml · nonDerivative · entry 1

Fiorentino Edward · CIK 0001666972 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 407,392

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $14,124.00 divided by $2.75, the closing price of Issuer's common stock on the NYSE American on January 3, 2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 23:14 UTC GrantCommon Stock 9,090 $2.75 $24,997.50
Disclosure

SEC source: 0001209191-22-001940 · doc4.xml · nonDerivative · entry 1

DeFalco Stephen P · CIK 0001666964 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,193,331

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $24,997.50 divided by $2.75, the closing price of Issuer's common stock on the NYSE American on January 3, 2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 23:17 UTC GrantCommon Stock 3,409 $2.75 $9,374.75
Disclosure

SEC source: 0001209191-22-001946 · doc4.xml · nonDerivative · entry 1

Prince Douglas S · CIK 0001666995 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 301,082

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,374.75 divided by $2.75, the closing price of Issuer's common stock on the NYSE American on January 3, 2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 23:15 UTC GrantCommon Stock 3,511 $2.75 $9,655.25
Disclosure

SEC source: 0001209191-22-001942 · doc4.xml · nonDerivative · entry 1

Steven Edelman · CIK 0001683354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 389,594

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,655.25 divided by $2.75, the closing price of Issuer's common stock on the NYSE American on January 3, 2022.

Read SEC document
December 08, 2021 Filed Dec 10, 2021 21:37 UTC GrantCommon Stock 72,115 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-069065 · doc4.xml · nonDerivative · entry 1

Larkin Sharon · CIK 0001898172 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,115

F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in three equal annual installments commencing on December 8, 2022, subject to the Reporting Person's continuous service through each such vesting date.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
December 06, 2021 Filed Dec 9, 2021 01:42 UTC SaleCommon Stock 136,538 $2.53 $345,441.14
Disclosure

SEC source: 0001209191-21-068630 · doc4.xml · nonDerivative · entry 2

Raab Anthony R. · CIK 0001827192 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,022

F3 · kind: Represents shares sold by the Reporting Person to satisfy the Reporting Person's tax obligations resulting from the settlement of restricted stock units ("RSUs") that vested on October 1, 2021. The sales were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 16, 2021.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.62 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 16, 2021 Filed Nov 18, 2021 14:22 UTC
JAIN MukulChief Operating Officer
SaleCommon Stock 100,000 $3.70 $370,000.00
Disclosure

SEC source: 0001209191-21-065378 · doc4.xml · nonDerivative · entry 2

JAIN Mukul · CIK 0001667593 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,739,124

F3 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.68 to $3.775 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 16, 2021 Filed Nov 18, 2021 14:23 UTC
Kaufman FrancineDirector · Chief Medical Officer
SaleCommon Stock 20,998 $3.70 $77,692.60
Disclosure

SEC source: 0001209191-21-065379 · doc4.xml · nonDerivative · entry 2

Kaufman Francine · CIK 0001769791 · Director · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,075,161

F2 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.69 to $3.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 15, 2021 Filed Nov 18, 2021 09:25 UTC
Panlilio MirasolVP Global Sales and Marketing
Tax withholdingCommon Stock 47,851 $3.80 $181,833.80
Disclosure

SEC source: 0001209191-21-065381 · doc4.xml · nonDerivative · entry 1

Panlilio Mirasol · CIK 0001667551 · VP Global Sales and Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 979,528

F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

Read SEC document
November 15, 2021 Filed Nov 18, 2021 14:29 UTC
Goodnow Timothy TDirector · President and CEO
Tax withholdingCommon Stock 297,995 $3.80 $1,132,381.00
Disclosure

SEC source: 0001209191-21-065383 · doc4.xml · nonDerivative · entry 1

Goodnow Timothy T · CIK 0001667588 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,528,908

F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

Read SEC document
November 15, 2021 Filed Nov 18, 2021 14:22 UTC
JAIN MukulChief Operating Officer
Tax withholdingCommon Stock 115,138 $3.80 $437,524.40
Disclosure

SEC source: 0001209191-21-065378 · doc4.xml · nonDerivative · entry 1

JAIN Mukul · CIK 0001667593 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,839,124

F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes 3,917 shares acquired under the Issuer's employee stock purchase plan on July 31, 2021.

Read SEC document
November 15, 2021 Filed Nov 18, 2021 14:26 UTC
Horton Kenneth LGC & Corp. Development Advisor
Tax withholdingCommon Stock 46,426 $3.80 $176,418.80
Disclosure

SEC source: 0001209191-21-065382 · doc4.xml · nonDerivative · entry 1

Horton Kenneth L · CIK 0001552047 · GC & Corp. Development Advisor

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,105,264

F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

Read SEC document
November 15, 2021 Filed Nov 18, 2021 14:24 UTC
Tressler Nick B.Chief Financial Officer
Tax withholdingCommon Stock 7,850 $3.80 $29,830.00
Disclosure

SEC source: 0001209191-21-065380 · doc4.xml · nonDerivative · entry 1

Tressler Nick B. · CIK 0001794362 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 214,429

F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes 4,512 shares acquired under the Issuer's employee stock purchase plan on July 31, 2021.

Read SEC document
November 15, 2021 Filed Nov 18, 2021 14:23 UTC
Kaufman FrancineDirector · Chief Medical Officer
Tax withholdingCommon Stock 55,531 $3.80 $211,017.80
Disclosure

SEC source: 0001209191-21-065379 · doc4.xml · nonDerivative · entry 1

Kaufman Francine · CIK 0001769791 · Director · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,096,159

F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 21:47 UTC GrantCommon Stock 4,094 $3.45 $14,124.30
Disclosure

SEC source: 0001209191-21-059633 · doc4.xml · nonDerivative · entry 1

Fiorentino Edward · CIK 0001666972 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 402,256

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $14,124.30 divided by $3.45, the closing price of Issuer's common stock on the NYSE American on October 1, 2021.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 21:49 UTC GrantCommon Stock 7,246 $3.45 $24,998.70
Disclosure

SEC source: 0001209191-21-059635 · doc4.xml · nonDerivative · entry 1

DeFalco Stephen P · CIK 0001666964 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,184,241

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $24,998.70 divided by $3.45, the closing price of Issuer's common stock on the NYSE American on October 1, 2021.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 21:46 UTC GrantCommon Stock 2,717 $3.45 $9,373.65
Disclosure

SEC source: 0001209191-21-059631 · doc4.xml · nonDerivative · entry 1

Prince Douglas S · CIK 0001666995 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 297,673

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,373.65 divided by $3.45, the closing price of Issuer's common stock on the NYSE American on October 1, 2021.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 21:47 UTC GrantCommon Stock 2,798 $3.45 $9,653.10
Disclosure

SEC source: 0001209191-21-059634 · doc4.xml · nonDerivative · entry 1

Steven Edelman · CIK 0001683354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 386,083

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,653.10 divided by $3.45, the closing price of Issuer's common stock on the NYSE American on October 1, 2021.

Read SEC document
August 25, 2021 Filed Aug 27, 2021 00:25 UTC Exercise / conversionStock Option (right to buy) · Derivative 86,930 $0.00 Strike: $1.97 $0.00
Disclosure

SEC source: 0001209191-21-053558 · doc4.xml · derivative · entry 6

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 86,930 shares

Expires 2029-05-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully vested and exercisable.

Read SEC document
August 25, 2021 Filed Aug 27, 2021 00:25 UTC Exercise / conversionStock Option (right to buy) · Derivative 128,817 $0.00 Strike: $1.35 $0.00
Disclosure

SEC source: 0001209191-21-053558 · doc4.xml · derivative · entry 5

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 128,817 shares

Expires 2027-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully vested and exercisable.

Read SEC document
August 25, 2021 Filed Aug 27, 2021 00:25 UTC SaleCommon Stock 215,747 $3.50 $755,114.50
Disclosure

SEC source: 0001209191-21-053558 · doc4.xml · nonDerivative · entry 4

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,483

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.47 to $3.57 inclusive.

Read SEC document
August 25, 2021 Filed Aug 27, 2021 00:25 UTC Exercise / conversionCommon Stock 86,930 $1.97 $171,252.10
Disclosure

SEC source: 0001209191-21-053558 · doc4.xml · nonDerivative · entry 3

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,230

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 25, 2021 Filed Aug 27, 2021 00:25 UTC Exercise / conversionCommon Stock 128,817 $1.35 $173,902.95
Disclosure

SEC source: 0001209191-21-053558 · doc4.xml · nonDerivative · entry 2

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 24, 2021 Filed Aug 27, 2021 00:25 UTC SaleCommon Stock 125,342 $3.65 $457,498.30
Disclosure

SEC source: 0001209191-21-053558 · doc4.xml · nonDerivative · entry 1

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,483

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.64 to $3.675 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2).

Read SEC document
July 01, 2021 Filed Jul 6, 2021 20:52 UTC GrantCommon Stock 4,035 $3.50 $14,122.50
Disclosure

SEC source: 0001209191-21-045527 · doc4.xml · nonDerivative · entry 1

Fiorentino Edward · CIK 0001666972 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 398,162

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $14,122.50 divided by $3.50, the closing price of Issuer's common stock on the NYSE American on July 1, 2021.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 20:59 UTC GrantCommon Stock 7,142 $3.50 $24,997.00
Disclosure

SEC source: 0001209191-21-045546 · doc4.xml · nonDerivative · entry 1

DeFalco Stephen P · CIK 0001666964 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,176,995

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $24,997.00 divided by $3.50, the closing price of Issuer's common stock on the NYSE American on July 1, 2021.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 20:53 UTC GrantCommon Stock 2,678 $3.50 $9,373.00
Disclosure

SEC source: 0001209191-21-045530 · doc4.xml · nonDerivative · entry 1

Prince Douglas S · CIK 0001666995 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 294,956

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,373.00 divided by $3.50, the closing price of Issuer's common stock on the NYSE American on July 1, 2021.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 20:50 UTC GrantCommon Stock 2,758 $3.50 $9,653.00
Disclosure

SEC source: 0001209191-21-045524 · doc4.xml · nonDerivative · entry 1

Steven Edelman · CIK 0001683354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 383,285

F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $9,653.00 divided by $3.50, the closing price of Issuer's common stock on the NYSE American on July 1, 2021.

Read SEC document
June 15, 2021 Filed Jun 16, 2021 18:17 UTC
Panlilio MirasolVP Global Sales and Marketing
Tax withholdingCommon Stock 8,602 $3.69 $31,741.38
Disclosure

SEC source: 0001209191-21-041051 · doc4.xml · nonDerivative · entry 1

Panlilio Mirasol · CIK 0001667551 · VP Global Sales and Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,027,379

F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes 12,000, 12,000 and 10,548 shares acquired under the Issuer's employee stock purchase plan on January 31, 2020, July 31, 2020 and January 29, 2021, respectively.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.